Russian scientists discover new proteins to treat neurological diseases

Scientists from Moscow State University, in cooperation with their colleagues from the SCALLOP consortium, have discovered new proteins for treating certain neurological diseases, such as schizophrenia, Alzheimer’s disease and alcoholism.

The university’s communications department said scientists have identified 283 regions of the genome where changes affect the level of protein biomarkers of neurological diseases, adding that the research team has identified for the first time the role of 174 sites in the development of these indicators.

In this regard, Anna Tymoshchuk, a researcher at the Advanced Research Institute of Artificial Intelligence and Intelligent Systems Problems at Moscow State University, said: “The research team also identified 13 new potential targets for treating diseases associated with neurological disorders, such as schizophrenia, Alzheimer’s disease and alcoholism.

It should be noted that proteins that move with blood plasma come from different tissues and cell types, affecting various biological processes occurring in the body, some of which serve as vital indicators of the development of diseases in the body, including neurological ones.

The expansion of the list of these proteins also helps to facilitate the diagnosis and treatment of diseases with great efficiency.